VREX on Nasdaq
Varex Imaging Corp
American electronic components company based in Wilmington, active since 2016. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Vicor Corporation, Advanced Energy or Impinj, or pick any stock.
- TickerVREX on Nasdaq2
- IndustryElectronic Components, NEC2
- HeadquartersWilmington, United States2
- Incorporated inDE4
- Business address1678 S. Pioneer Road, Salt Lake City, Ut 841044
- Filer categoryAccelerated filer4
- Legal formCorporation2
- LEI549300CWYWPVCT8E9W672
- StatusActive2
- LEI statusIssued and current2
- Registered addressC/O UNITED AGENT GROUP INC., 19803 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 60674282
See how the biggest companies compare on our leaderboards
Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components including X-ray tubes, flat panel and photon counting detectors and accessories, linear accelerators, image software processing solutions, and stand-alone X-ray based systems in select application areas. Our components are used in medical diagnostic imaging, security inspection systems, and industrial quality inspection systems, as well as for analysis and measurement applications in industrial manufacturing applications. Global OEMs incorporate our X-ray imaging components into their systems to detect, diagnose, protect, irradiate, and inspect. Varex has approximately 2,400 full-time equivalent employees, located at engineering, manufacturing, and service center sites in North America, Europe, and Asia.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
34.4%Gross margin3
-3.3%Operating margin3
-8.3%Net margin3
4.1%Revenue growth, 20253
-14.9%Return on equity3
0.77×Debt to equity3
$18.8MFree cash flow3
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Medical brought in 70% of the revenue Varex Imaging Corp broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Medical | $673.3M | $581.7M | $592.6M |
| Industrial | $220.1M | $229.3M | $252.0M |
Regions
Other Countries brought in 19% of the revenue Varex Imaging Corp broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| Other Countries | $314.9M | $317.2M | $317.9M |
| EMEA | $290.7M | $280.3M | $284.8M |
| Asia Pacific | $320.9M | $264.2M | $283.3M |
| Americas | $281.8M | $266.5M | $276.5M |
| United States | $275.1M | $257.7M | $254.9M |
| Japan | $156.6M | $118.1M | $143.5M |
| China | $146.8M | $118.0M | $128.3M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue66¢$554.1M
- Research and development11¢$91.1M
- Selling, general and admin16¢$133.3M
- Other costs7¢$55.4M
- Income tax1¢$10.7M
Out of $844.6M in revenue.3 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending55¢$22.9M
- Kept or used elsewhere45¢$18.8M
Out of $41.7M of cash from operations.3
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-09-30 | 2024-09-30 | 2023-09-30 |
|---|---|---|---|
| Revenues, net | $844.6M | $811.0M | $893.4M |
| Cost of revenues | $554.1M | $554.1M | $603.1M |
| Gross profit | $290.5M | $256.9M | $290.3M |
| Research and development | $91.1M | $87.0M | $84.8M |
| Selling, general, and administrative | $133.3M | $137.8M | $128.4M |
| Impairment of goodwill | $93.9M | $0 | $0 |
| Total operating expenses | $318.3M | $224.8M | $213.2M |
| Operating (loss) income | -$27.8M | $32.1M | $77.1M |
| Interest income | $8.5M | $7.3M | $3.7M |
| Interest expense | -$35.5M | -$30.2M | -$29.3M |
| Other expense, net | -$4.4M | -$4.2M | -$20.2M |
| Interest and other expense, net | -$31.4M | -$27.1M | -$45.8M |
| (Loss) income before taxes | -$59.2M | $5.0M | $31.3M |
| Income tax expense (benefit) | $10.7M | $53.3M | -$16.6M |
| Net (loss) income | -$69.9M | -$48.3M | $47.9M |
| Less: Net income attributable to noncontrolling interests | $400.0K | $500.0K | $500.0K |
| Net (loss) income attributable to Varex | -$70.3M | -$48.8M | $47.4M |
| Basic (in USD per share) | -$1.70 | -$1.20 | $1.18 |
| Diluted (in USD per share) | -$1.70 | -$1.20 | $1.07 |
| Basic (in shares) | 41.4M shares | 40.8M shares | 40.3M shares |
| Diluted (in shares) | 41.4M shares | 40.8M shares | 50.3M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.3
| Period ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | $145.0M | $168.7M | $152.6M | |
| Marketable securities | $10.1M | $31.8M | ||
| Accounts receivable, net of allowance for credit losses of $2.1 million and $1.0 million at October 3, 2025 and September 27, 2024, respectively | $156.6M | $157.7M | ||
| Inventories, net | $299.4M | $264.8M | ||
| Prepaid expenses and other current assets | $30.7M | $26.9M | ||
| Total current assets | $641.8M | $649.9M | ||
| Property, plant, and equipment, net | $157.8M | $153.4M | ||
| Goodwill | $198.4M | $291.0M | ||
| Intangible assets, net | $14.0M | $16.1M | ||
| Investments in privately-held companies | $24.5M | $26.8M | ||
| Deferred tax assets | $2.9M | $1.3M | ||
| Operating lease assets | $29.4M | $28.3M | ||
| Other assets | $38.6M | $46.8M | ||
| Total assets | $1.1B | $1.2B | ||
| Accounts payable | $69.9M | $59.1M | ||
| Accrued liabilities and other current liabilities | $98.4M | $78.6M | ||
| Current operating lease liabilities | $4.4M | $4.0M | ||
| Current maturities of long-term debt, net | $1.5M | $46.3M | ||
| Deferred revenues | $13.0M | $7.9M | ||
| Total current liabilities | $187.2M | $195.9M | ||
| Long-term debt, net | $366.0M | $397.1M | ||
| Deferred tax liabilities | $5.5M | $4.0M | ||
| Operating lease liabilities | $24.0M | $23.0M | ||
| Other long-term liabilities | $38.1M | $50.4M | ||
| Total liabilities | $620.8M | $670.4M | ||
| Preferred stock, $0.01 par value: 20,000,000 shares authorized, none issued | $0 | $0 | ||
| Common stock, $.01 par value: 150,000,000 shares authorized; shares issued and outstanding: 40,860,965 and 40,529,573 at June 28, 2024 and September 29, 2023, respectively | $400.0K | $400.0K | ||
| Additional paid-in capital | $483.3M | $467.2M | ||
| Accumulated other comprehensive loss | -$5.2M | -$2.9M | ||
| (Accumulated deficit) retained earnings | -$5.9M | $64.4M | ||
| Total Varex stockholders' equity | $472.6M | $529.1M | ||
| Noncontrolling interests | $14.0M | $14.1M | $13.3M | |
| Total stockholders' equity | $486.6M | $543.2M | $576.1M | $542.6M |
| Total liabilities and stockholders' equity | $1.1B | $1.2B | ||
| Accounts receivable, allowance for doubtful accounts | $2.1M | $1.0M | ||
| Preferred stock, par value (in USD per share) | $0.01 | $0.01 | ||
| Preferred stock, shares authorized (in shares) | 20.0M shares | 20.0M shares | ||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Common stock, par value per share (in USD per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (in shares) | 150.0M shares | 150.0M shares | ||
| Common stock, shares, issued (in shares) | 41.7M shares | 41.1M shares | ||
| Common stock, shares, outstanding (in shares) | 41.7M shares | 41.1M shares |
| Period ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | $145.0M | $168.7M | $152.6M | |
| Marketable securities | $10.1M | $31.8M | ||
| Accounts receivable, net of allowance for credit losses of $2.1 million and $1.0 million at October 3, 2025 and September 27, 2024, respectively | $156.6M | $157.7M | ||
| Inventories, net | $299.4M | $264.8M | ||
| Prepaid expenses and other current assets | $30.7M | $26.9M | ||
| Total current assets | $641.8M | $649.9M | ||
| Property, plant, and equipment, net | $157.8M | $153.4M | ||
| Goodwill | $198.4M | $291.0M | ||
| Intangible assets, net | $14.0M | $16.1M | ||
| Investments in privately-held companies | $24.5M | $26.8M | ||
| Deferred tax assets | $2.9M | $1.3M | ||
| Operating lease assets | $29.4M | $28.3M | ||
| Other assets | $38.6M | $46.8M | ||
| Total assets | $1.1B | $1.2B | ||
| Accounts payable | $69.9M | $59.1M | ||
| Accrued liabilities and other current liabilities | $98.4M | $78.6M | ||
| Current operating lease liabilities | $4.4M | $4.0M | ||
| Current maturities of long-term debt, net | $1.5M | $46.3M | ||
| Deferred revenues | $13.0M | $7.9M | ||
| Total current liabilities | $187.2M | $195.9M | ||
| Long-term debt, net | $366.0M | $397.1M | ||
| Deferred tax liabilities | $5.5M | $4.0M | ||
| Operating lease liabilities | $24.0M | $23.0M | ||
| Other long-term liabilities | $38.1M | $50.4M | ||
| Total liabilities | $620.8M | $670.4M | ||
| Preferred stock, $0.01 par value: 20,000,000 shares authorized, none issued | $0 | $0 | ||
| Common stock, $.01 par value: 150,000,000 shares authorized; shares issued and outstanding: 40,860,965 and 40,529,573 at June 28, 2024 and September 29, 2023, respectively | $400.0K | $400.0K | ||
| Additional paid-in capital | $483.3M | $467.2M | ||
| Accumulated other comprehensive loss | -$5.2M | -$2.9M | ||
| (Accumulated deficit) retained earnings | -$5.9M | $64.4M | ||
| Total Varex stockholders' equity | $472.6M | $529.1M | ||
| Noncontrolling interests | $14.0M | $14.1M | $13.3M | |
| Total stockholders' equity | $486.6M | $543.2M | $576.1M | $542.6M |
| Total liabilities and stockholders' equity | $1.1B | $1.2B | ||
| Accounts receivable, allowance for doubtful accounts | $2.1M | $1.0M | ||
| Preferred stock, par value (in USD per share) | $0.01 | $0.01 | ||
| Preferred stock, shares authorized (in shares) | 20.0M shares | 20.0M shares | ||
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Common stock, par value per share (in USD per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (in shares) | 150.0M shares | 150.0M shares | ||
| Common stock, shares, issued (in shares) | 41.7M shares | 41.1M shares | ||
| Common stock, shares, outstanding (in shares) | 41.7M shares | 41.1M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-09-30 | 2024-09-30 | 2023-09-30 |
|---|---|---|---|
| Net (loss) income | -$69.9M | -$48.3M | $47.9M |
| Share-based compensation expense | $15.0M | $15.3M | $13.5M |
| Depreciation | $23.2M | $21.2M | $19.5M |
| Amortization of intangible assets | $4.0M | $9.9M | $13.7M |
| Deferred taxes | -$500.0K | $38.1M | -$38.7M |
| Loss from equity method investments | $2.7M | $2.0M | $1.6M |
| Impairment of equity method investment | $0 | $0 | $16.4M |
| Amortization of deferred loan costs | $2.7M | $2.8M | $2.6M |
| Gain on purchase of business | $0 | -$2.1M | $0 |
| Impairment of goodwill | $93.9M | $0 | $0 |
| Inventory write-down | $3.8M | $4.9M | $5.6M |
| Other, net | -$1.8M | $1.5M | $3.0M |
| Accounts receivable | $100.0K | $6.7M | $9.8M |
| Inventories, net | -$39.9M | $6.6M | $20.2M |
| Prepaid expenses and other assets | -$3.6M | $3.3M | $7.0M |
| Accounts payable | $6.2M | -$3.2M | -$15.0M |
| Accrued liabilities and other current and long-term liabilities | $100.0K | -$9.1M | -$1.0M |
| Deferred revenues | $5.7M | -$2.3M | $2.3M |
| Net cash provided by operating activities | $41.7M | $47.3M | $108.4M |
| Purchases of property, plant, and equipment | -$22.9M | -$26.9M | -$20.7M |
| Loss on settlement of cash flow hedge | $0 | $0 | -$200.0K |
| Proceeds from sales of marketable debt securities | $11.5M | $0 | $0 |
| Proceeds from maturities of marketable debt securities | $50.5M | $58.8M | $28.3M |
| Purchase of marketable debt securities | -$30.6M | -$56.6M | -$52.2M |
| Purchase of marketable equity securities | $0 | -$200.0K | -$2.7M |
| Purchase of certificates of deposit | $0 | -$4.2M | -$1.0M |
| Proceeds from maturities of certificates of deposit | $3.4M | $1.8M | $0 |
| Settlement of net investment hedge | $7.0M | ||
| Settlement of net investment hedge | -$800.0K | $0 | |
| Acquisitions of businesses, net of cash acquired | $0 | $900.0K | -$1.0M |
| Other, net | -$800.0K | -$1.1M | -$2.4M |
| Net cash provided by (used in) investing activities | $10.3M | -$27.5M | -$44.9M |
| Taxes related to net share settlement of equity awards | -$1.9M | -$2.2M | -$1.4M |
| Proceeds from issuance of senior secured notes | $126.9M | $0 | $0 |
| Repayments of borrowings | -$201.9M | -$1.6M | -$2.4M |
| Proceeds from exercise of stock options | $0 | $0 | $200.0K |
| Payment of debt issuance costs | -$1.2M | -$2.3M | $0 |
| Proceeds from shares issued under employee stock purchase plan | $3.3M | $3.8M | $3.9M |
| Other, net | -$1.1M | -$1.0M | -$500.0K |
| Net cash used in financing activities | -$75.9M | -$3.3M | -$200.0K |
| Effects of exchange rate changes on cash and cash equivalents and restricted cash | $600.0K | -$100.0K | $100.0K |
| Net (decrease) increase in cash and cash equivalents and restricted cash | -$23.3M | $16.4M | $63.4M |
| Cash paid for interest | $31.3M | $27.6M | $27.4M |
| Income taxes paid, net of refunds | $18.6M | $20.2M | $16.7M |
| Purchases of property, plant, and equipment financed through accounts payable | $5.4M | $1.0M | $2.7M |
No quarter-by-quarter statement was filed.
Leadership
Who has led Varex Imaging Corp, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
20202025
- Chief executive officerSunny Sanyal Jan 19, 2017 to now15
- PresidentSunny Sanyal Jan 19, 2017 to now15
- Chief financial officerShubham Maheshwari Aug 4, 2020 to now16
- Chief financial officerClarence R. Verhoef Jan 19, 2017 to Feb 19, 202017
Board members and other officers (23)
- SVP and GM, IndustrialJesse Don Merkley Mar 27, 2026 to now18
- Chief Human Resources OfficerKaren L. Aranki Feb 13, 2024 to now19
- SVP Sales & Marketing, MedicalAndrew Hartmann Feb 18, 2021 to now20
- Vice President and SecretaryKimberley E. Honeysett Jan 19, 2017 to Jan 19, 201721
- SVP, Sales & MarketingCarl E. Lacasce Jan 30, 2017 to Jun 7, 201822
- SVP and GM, X-Ray SourcesMark S. Jonaitis Jan 30, 2017 to now23
- SVP and GM, X-Ray DetectorsRichard E. Colbeth Jan 30, 2017 to Feb 17, 201724
- Controller & CAOKevin Bruce Yankton Feb 6, 2017 to Feb 22, 202125
- SVP and GM, X-ray DetectorsBrian W. Giambattista May 8, 2017 to Feb 17, 202326
- Board memberKathleen Bardwell Aug 5, 2022 to now27
- Board memberTimothy E. Guertin Sep 10, 2020 to now28
- Board memberWalter M. Rosebrough Jr. Apr 26, 2018 to now29
- Board memberElisha W. Finney Jan 19, 2017 to Jan 19, 201730
- Board memberJohn W. Kuo Jan 19, 2017 to Jan 19, 201731
- Board memberSunny Sanyal Jan 19, 2017 to now15
- Board memberChristine A. Tsingos Jan 30, 2017 to now32
- Board memberDow R. Wilson Jan 30, 2017 to Feb 20, 201833
- Board memberErich R. Reinhardt Jan 30, 2017 to Feb 18, 202034
- Board memberJay K. Kunkel Jan 30, 2017 to now35
- Board memberRuediger Naumann-Etienne Jan 30, 2017 to Feb 13, 202336
- Board memberJocelyn D. Chertoff Apr 4, 2017 to now37
- General counselMatthew Aaron Martinez Oct 16, 2025 to now38
- General counselKimberley E. Honeysett Jan 31, 2017 to now39
Timeline
Filings
268 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 37 major events, 129 insider forms, 35 large holders, 47 other. The latest 20:
- Oct 14, 20264 EDGAR
- Oct 7, 2026SCHEDULE 13G/A EDGAR
- Oct 5, 2026SCHEDULE 13G/A EDGAR
- Sep 21, 2026DEFM14A EDGAR
- Sep 15, 20264 EDGAR
- Sep 15, 20264 EDGAR
- Sep 14, 2026144 EDGAR
- Sep 11, 2026144 EDGAR
- Sep 8, 2026PREM14A EDGAR
- Aug 18, 20264 EDGAR
- Aug 12, 2026DEFA14A DEFA14A - VAREX CUSTOMER TALKING POINTS FAQ EDGAR
- Aug 10, 2026DEFA14A DEFA14A - ANNOUNCEMENTS TO EMPLOYEES EDGAR
- Aug 10, 2026DEFA14A DEFA14A - LETTER TO CUSTOMERS EDGAR
- Aug 10, 2026DEFA14A DEFA14A - LETTER TO SUPPLIERS EDGAR
- Aug 10, 202610-Q EDGAR
- Aug 10, 2026DEFA14A EDGAR
- Aug 10, 20268-K EDGAR
- Aug 10, 20268-K EDGAR
- Jul 31, 2026SCHEDULE 13G EDGAR
- May 28, 2026SD EDGAR
The 268 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
21 open-market trades by officers, directors and large owners since October 2021: 2 buys and 19 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Kunkel Jay K.Director | Sale | 8,121 | $18.48 | $150.1K | Form 4 |
| Sep 11, 2026 | Maheshwari ShubhamChief Financial Officer | Sale | 130,000 | $18.46 | $2.4M | Form 4 |
| Mar 20, 2026 | Kunkel Jay K.Director | Sale | 4,510 | $11.14 | $50.2K | Form 4 |
| Sep 19, 2025 | Aranki Karen LChief Human Resources Officer | Sale | 3,174 | $12.34 | $39.2K | Form 4 |
| Aug 14, 2025 | Kunkel Jay K.Director | Sale | 3,000 | $10.49 | $31.5K | Form 4 |
| Jun 18, 2025 | Kunkel Jay K.Director | Sale | 2,575 | $7.77 | $20.0K | Form 4 |
| Apr 2, 2025 | SANYAL SUNNYPresident and CEO | Sale | 8,749 | $11.24 | $98.3K | Form 4 |
| Mar 20, 2025 | Honeysett Kimberley E.SVP and CLO | Sale | 4,007 | $12.81 | $51.3K | Form 4 |
| Aug 20, 2024 | Honeysett Kimberley E.SVP and CLO | Sale | 2,578 | $12.53 | $32.3K | Form 4 |
| Aug 12, 2024 | Maheshwari ShubhamChief Financial Officer | Buy | 10,000 | $10.82 | $108.2K | Form 4 |
| Aug 9, 2024 | Maheshwari ShubhamChief Financial Officer | Buy | 9,007 | $10.98 | $98.9K | Form 4 |
| Mar 15, 2024 | Honeysett Kimberley E.SVP and CLO | Sale | 2,860 | $17.37 | $49.7K | Form 4 |
| Nov 22, 2023 | Honeysett Kimberley E.SVP and CLO | Sale | 6,174 | $19.72 | $121.8K | Form 4 |
| Jun 16, 2023 | Honeysett Kimberley E.SVP and CLO | Sale | 2,909 | $23.20 | $67.5K | Form 4 |
| May 8, 2023 | Kunkel Jay K.Director | Sale | 9,120 | $21.90 | $199.7K | Form 4 |
| Aug 24, 2022 | NAUMANN-ETIENNE RUEDIGERDirector | Sale | 5,000 | $21.60 | $108.0K | Form 4 |
| Aug 18, 2022 | Honeysett Kimberley E.SVP and CLO | Sale | 3,028 | $23.50 | $71.2K | Form 4 |
| Jun 6, 2022 | NAUMANN-ETIENNE RUEDIGERDirector | Sale | 5,207 | $22.62 | $117.8K | Form 4 |
| Dec 29, 2021 | SANYAL SUNNYPresident and CEO | Sale | 31,428 | $32.28 | $1.0M | Form 4 |
| Dec 28, 2021 | SANYAL SUNNYPresident and CEO | Sale | 30,473 | $32.01 | $975.4K | Form 4 |
All 21 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Allspring Global Investments Holdings, LLCSCHEDULE 13G/A, 4 filings Jan 12, 2023 to Oct 7, 202640
- PZENA INVESTMENT MANAGEMENT LLCSCHEDULE 13G/A, 3 filings Oct 15, 2024 to Oct 5, 202641
- VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Jul 31, 202642
- VANGUARD GROUP INCSCHEDULE 13G/A, 8 filings Feb 10, 2022 to Mar 27, 202643
- DIMENSIONAL FUND ADVISORS LPSCHEDULE 13G/A, 3 filings Feb 9, 2024 to Oct 9, 202544
- COOKE & BIELER LPSCHEDULE 13G/A, 2 filings Feb 13, 2024 to Feb 12, 202545
- SHAPIRO CAPITAL MANAGEMENT LLCSCHEDULE 13G, 5 filings Oct 7, 2021 to Nov 14, 202446
- BlackRockSC 13G/A, 1 filing Oct 7, 202447
- Janus Henderson Group Ltd.SC 13G/A, 2 filings Feb 13, 2023 to Feb 12, 202448
- State Street CorporationSC 13G/A, 2 filings Feb 3, 2023 to Jan 23, 202449
- Wells FargoSC 13G/A, 1 filing Jan 27, 202250
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27SEC EDGARKathleen Bardwell, Board member
- 28SEC EDGARTimothy E. Guertin, Board member
- 29
- 30SEC EDGARElisha W. Finney, Board member
- 31SEC EDGARJohn W. Kuo, Board member
- 32SEC EDGARChristine A. Tsingos, Board member
- 33SEC EDGARDow R. Wilson, Board member
- 34SEC EDGARErich R. Reinhardt, Board member
- 35SEC EDGARJay K. Kunkel, Board member
- 36
- 37SEC EDGARJocelyn D. Chertoff, Board member
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50